Export 24 results:
Author [ Title(Desc)] Type Year
Filters: Author is Milton, RC  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., Milton, R. C., and Group, T. P. K. C. D. R. S. 2 S., Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
E
R. C. Milton, Ferris, III, F. L., Gensler, G. R., Ho, M., Davis, M. D., Clemons, T. E., Chew, E. Y., and Group, A. - R. Eye Diseas, The Effect of Cataract Surgery on the Development of Geographic Atrophy, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
S. B. Bressler, Ferris, F. L., Milton, R. C., Gensler, G., Harrington, M., Kim, J., Chew, E. Y., and Group, A. - R. Eye Diseas, The Effect of Cataract Surgery on the Development of Neovascular Age-Related Macular Degeneration (AMD), 2006.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Hu, K., Girach, A., and Vignati, L., The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME), in 15th Scientific Meeting of the Eye Complications Study Group of the European Association for the Study of Diabetes (EASDec), Coimbra, Portugal, 2005.
R. P. Danis, Sheetz, M. J., Aiello, L. P., Davis, M. D., Milton, R. C., Girach, A., Zhi, X., and Group, V. L. for the, Effect of Ruboxistaurin on reversibility of vision loss in nonproliferative diabetic retinopathy patients, 2006.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Arora, V., Hu, K., Girach, A., and Vignati, L., The Effect of Ruboxistaurin (RBX), a PKC b Inhibitor, on Visual Acuity (VA) Loss Due to Diabetic Macular Edema (DME), 2004.
L. P. Aiello, Vignati, L., ,, Zhi, X., Davis, M. D., Milton, R. C., and Group, G. A. for the, Effect of the oral PKC b Inhibitor, Ruboxistaurin, on vision loss in patients with diabetic retinopathy: The PKC-DRS2 study results, 2006.
R. P. Danis, Girach, A., Aiello, L. P., Davis, M. D., Milton, R. C., Sheetz, M. J., Lin, T. E., Zhi, X., and Group, V. L. for the, The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema, in 24th Annual American society of Retinal Specialists and the 6th Annual European Vitreoretinal Society Meeting, Cannes, France, 2006.
L. Vignati, Sheetz, M. J., Girach, A., Zhi, X., Davis, M. D., Milton, R. C., and Group, Afor the P. K., Effect of the oral protein kinase C b Inhibitor, Ruboxistaurin, on visual acuity in the PKC-DRS2 Study, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., Milton, R. C., and Group, T. P. K. C. D. R. S. 2 S., The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results, in American Academy of Ophthalmology, Chicago, IL, 2005.